Investors Alert: Cablevision Systems Corporation (NYSE:CVC), Pacific Biosciences of California (NASDAQ:PACB), CTC Media, Inc (NASDAQ:CTCM), Arena Pharmaceuticals (NASDAQ:ARNA), Baidu (NASDAQ:BIDU)

On Friday shares of Cablevision Systems Corporation (NYSE:CVC) closed at $20.15. Company’s sales growth for last 5 years was 2.10% and EPS growth for next 5 years is recorded as -1.05%. Cablevision Systems Corporation (NYSE:CVC) has unveiled a new internet-focused Optimum product targeting the ‘cord cutter’ and ‘cord never’ generation of consumers.

Pacific Biosciences of California, Inc. (NASDAQ:PACB) in last trading activity decreased -2.37% to close at $5.76. Company weekly performance is -6.34% while its quarterly performance stands at -26.90%. Pacific Biosciences of California, Inc. (NASDAQ:PACB) is -34.40% away from its 52 week high. Pacific Biosciences of California Inc (NASDAQ:PACB) will hold its quarterly conference call to discuss its First Quarter 2015 Financial Results on Tuesday, May 5, 2015, at 4:30pm Eastern Time.

On last trading day CTC Media, Inc (NASDAQ:CTCM) decreased -4.07% to close at $4.24. Its volatility for the week is 3.80% while volatility for the month is 4.30%. CTCM’s sales growth for past 5 years was 7.00% and its EPS growth for past 5 years was 1.50%. CTC Media, Inc (NASDAQ:CTCM) monthly performance is 8.44%. CTC Media Inc. (NASDAQ:CTCM) on 22 April, announced a partnership with Wildberries, one of the largest online retailers in Russia. The partnership will expand sales of CTC Media’s “Sweet Me” women’s clothing brand, which was initially launched in April 2014.

On Friday shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) closed at $4.49. Company’s sales growth for last 5 years was 28.90%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai announced Friday the completion of two Phase 1 registrational clinical trials that demonstrate the bioequivalence of an investigational once-daily extended release form of lorcaserin — a weight-loss treatment — as compared to the twice-daily immediate release formulation of Belviq, approved by the FDA.

Baidu Inc (ADR) (NASDAQ:BIDU) in last trading activity increased 2.18% to close at $216.90. Company weekly performance is 4.34% while its quarterly performance stands at -7.04%. Baidu Inc (ADR) (NASDAQ:BIDU) is -13.93% away from its 52 week high. Baidu Inc (ADR) (NASDAQ:BIDU) is set to make some major strategic adjustments in its global expansion. The company is looking to expand in non-western markets for its global foray. The company has also withdrawn from the Japanese market.

Leave a Reply

Your email address will not be published. Required fields are marked *

*